RHHBY
Price
$40.88
Change
-$0.03 (-0.07%)
Updated
Aug 28 closing price
Capitalization
260.55B
55 days until earnings call
SNPHY
Price
$10.61
Change
+$0.39 (+3.82%)
Updated
Aug 28 closing price
Capitalization
3.52B
Interact to see
Advertisement

RHHBY vs SNPHY

Header iconRHHBY vs SNPHY Comparison
Open Charts RHHBY vs SNPHYBanner chart's image
Roche Holding
Price$40.88
Change-$0.03 (-0.07%)
Volume$2.87M
Capitalization260.55B
Santen Pharmaceutical
Price$10.61
Change+$0.39 (+3.82%)
Volume$2.5K
Capitalization3.52B
RHHBY vs SNPHY Comparison Chart in %
Loading...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBY vs. SNPHY commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBY is a Buy and SNPHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (RHHBY: $40.88 vs. SNPHY: $10.61)
Brand notoriety: RHHBY and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBY: 212% vs. SNPHY: 66%
Market capitalization -- RHHBY: $260.55B vs. SNPHY: $3.52B
RHHBY [@Pharmaceuticals: Major] is valued at $260.55B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.52B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBY’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 1 green FA rating(s).

  • RHHBY’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 1 green, 4 red.
According to our system of comparison, both RHHBY and SNPHY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBY’s TA Score shows that 7 TA indicator(s) are bullish while SNPHY’s TA Score has 4 bullish TA indicator(s).

  • RHHBY’s TA Score: 7 bullish, 3 bearish.
  • SNPHY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than SNPHY.

Price Growth

RHHBY (@Pharmaceuticals: Major) experienced а +1.06% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +1.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.84%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +11.90%.

Reported Earning Dates

RHHBY is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($261B) has a higher market cap than SNPHY($3.52B). RHHBY has higher P/E ratio than SNPHY: RHHBY (22.39) vs SNPHY (15.09). RHHBY YTD gains are higher at: 21.099 vs. SNPHY (4.842). SNPHY has higher annual earnings (EBITDA): 51.1B vs. RHHBY (18B). SNPHY has more cash in the bank: 85.9B vs. RHHBY (12B). SNPHY has higher revenues than RHHBY: SNPHY (303B) vs RHHBY (63.5B).
RHHBYSNPHYRHHBY / SNPHY
Capitalization261B3.52B7,421%
EBITDA18B51.1B35%
Gain YTD21.0994.842436%
P/E Ratio22.3915.09148%
Revenue63.5B303B21%
Total Cash12B85.9B14%
Total Debt33BN/A-
FUNDAMENTALS RATINGS
RHHBY vs SNPHY: Fundamental Ratings
RHHBY
SNPHY
OUTLOOK RATING
1..100
1472
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5662
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (12) in the null industry is in the same range as SNPHY (31). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's Profit vs Risk Rating (84) in the null industry is in the same range as SNPHY (100). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's SMR Rating (100) in the null industry is in the same range as SNPHY (100). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's Price Growth Rating (56) in the null industry is in the same range as SNPHY (62). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBY's P/E Growth Rating (100) in the null industry is in the same range as SNPHY (100). This means that RHHBY’s stock grew similarly to SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBYSNPHY
RSI
ODDS (%)
Bullish Trend 2 days ago
53%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 10 days ago
54%
Declines
ODDS (%)
Bearish Trend 19 days ago
46%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDJX19.910.14
+0.71%
Artisan International Small-Mid Advisor
PEIYX38.18N/A
N/A
Putnam Large Cap Value Y
FLMAX10.09N/A
N/A
Meeder Muirfield Adviser
ABMIX24.40N/A
N/A
AMG River Road Mid Cap Value I
LMVOX29.98N/A
N/A
Lord Abbett Focused Small Cap Value F3

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-0.07%
RHHVF - RHHBY
65%
Loosely correlated
-1.80%
NVS - RHHBY
37%
Loosely correlated
-0.33%
JNJ - RHHBY
37%
Loosely correlated
-0.76%
RHHBF - RHHBY
32%
Poorly correlated
-3.04%
BMY - RHHBY
28%
Poorly correlated
-1.57%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and RHHBF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
+3.82%
RHHBF - SNPHY
9%
Poorly correlated
-3.04%
RHHVF - SNPHY
9%
Poorly correlated
-1.80%
RHHBY - SNPHY
6%
Poorly correlated
-0.07%
OTSKY - SNPHY
3%
Poorly correlated
+0.38%
SNPHF - SNPHY
1%
Poorly correlated
N/A
More